Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gedda

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta. Biomembranes|November 18, 2023
A closer look at calcium-induced interactions between phosphatidylserine-(PS) doped liposomes and the structural effects caused by inclusion of gangliosides or polyethylene glycol- (PEG) modified lipidsPhilipp Grad, Katarina Edwards, Lars Gedda, et al.
Plos One|September 21, 2011
Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²⁵I-EGFHanna Björkelund, Lars Gedda, Pavel Barta, et al.
International Journal of Pharmaceutics|February 16, 2026
Lyophilization of Curcumin-Loaded Lipodisks; pre- and post-processing evaluation of formulation characteristicsSajid Ali, Luís Silva, Lars Gedda, et al.
FEMS Microbiology Ecology|October 26, 2023
Vesicle-enriched secretomes alter bacterial competitive abilities and are drivers of evolution in microbial communitiesOmar M Warsi, Lars Gedda, Katarina Edwards, et al.
Nuclear Medicine and Biology|August 29, 2006
A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapyLudger M Ickenstein, Katarina Edwards, Stefan Sjöberg, et al.
Soft Matter|February 14, 2024
Investigation of supramolecular structures in various aqueous solutions of an amyloid forming peptide using small-angle X-ray scatteringEllen Brunzell, Kalle Sigfridsson, Lars Gedda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
Experimental radionuclide therapy of HER2-expressing xenografts using two-step targeting nuclisome particlesLars Gedda, Amelie Fondell, Hans Lundqvist, et al.
Journal of Tissue Engineering and Regenerative Medicine|August 29, 2012
Characterization of recombinant human bone morphogenetic protein-2 delivery from injectable hyaluronan-based hydrogels by means of 125I-radiolabellingSonya Piskounova, Lars Gedda, Gry Hulsart-Billström, et al.
Journal of Colloid and Interface Science|June 17, 2025
Development and in vitro evaluation of lipodisks optimized for co-delivery of chemotherapeutic drugs and membranolytic anticancer peptidesLuís Silva, Sajid Ali, Lars Gedda, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 4, 2009
Flow cytometric in situ proximity ligation analyses of protein interactions and post-translational modification of the epidermal growth factor receptor familyKarl-Johan Leuchowius, Irene Weibrecht, Ulf Landegren, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta. Biomembranes|November 18, 2023
A closer look at calcium-induced interactions between phosphatidylserine-(PS) doped liposomes and the structural effects caused by inclusion of gangliosides or polyethylene glycol- (PEG) modified lipidsPhilipp Grad, Katarina Edwards, Lars Gedda, et al.
Plos One|September 21, 2011
Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²⁵I-EGFHanna Björkelund, Lars Gedda, Pavel Barta, et al.
International Journal of Pharmaceutics|February 16, 2026
Lyophilization of Curcumin-Loaded Lipodisks; pre- and post-processing evaluation of formulation characteristicsSajid Ali, Luís Silva, Lars Gedda, et al.
FEMS Microbiology Ecology|October 26, 2023
Vesicle-enriched secretomes alter bacterial competitive abilities and are drivers of evolution in microbial communitiesOmar M Warsi, Lars Gedda, Katarina Edwards, et al.
Nuclear Medicine and Biology|August 29, 2006
A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapyLudger M Ickenstein, Katarina Edwards, Stefan Sjöberg, et al.
Soft Matter|February 14, 2024
Investigation of supramolecular structures in various aqueous solutions of an amyloid forming peptide using small-angle X-ray scatteringEllen Brunzell, Kalle Sigfridsson, Lars Gedda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
Experimental radionuclide therapy of HER2-expressing xenografts using two-step targeting nuclisome particlesLars Gedda, Amelie Fondell, Hans Lundqvist, et al.
Journal of Tissue Engineering and Regenerative Medicine|August 29, 2012
Characterization of recombinant human bone morphogenetic protein-2 delivery from injectable hyaluronan-based hydrogels by means of 125I-radiolabellingSonya Piskounova, Lars Gedda, Gry Hulsart-Billström, et al.
Journal of Colloid and Interface Science|June 17, 2025
Development and in vitro evaluation of lipodisks optimized for co-delivery of chemotherapeutic drugs and membranolytic anticancer peptidesLuís Silva, Sajid Ali, Lars Gedda, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 4, 2009
Flow cytometric in situ proximity ligation analyses of protein interactions and post-translational modification of the epidermal growth factor receptor familyKarl-Johan Leuchowius, Irene Weibrecht, Ulf Landegren, et al.
Pageof 7